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Abstract
Background: Choroidal metastases from gynaecological primary are extremely rare. There is no
documented case in the literature of choroid metastasis in a patient with primary peritoneal
carcinoma (PPC).
Methods & Results: We describe the first case of a 54-year-old woman with a history of
borderline mucinous tumour who presented 17 months later with PPC and 21 months after with
recurrent disease metastatic to the eye, and review pertinent literature.
Conclusion: High index of suspicion is warranted when patients with history of primary peritoneal
carcinoma present with visual complaints in order to treat and/or relieve symptomatology from
metastatic eye disease.
Background
Primary peritoneal carcinoma (PPC) is a rare tumour that
is histologically similar to primary epithelial ovarian car-
cinoma (EOC). Its diagnosis is based on the extent of
gross ovarian involvement and microscopic invasion of
the ovarian cortex. It diffusely involves the peritoneal cav-
ity often with extensive disease in the upper abdomen
affecting mostly the omentum, while sparing or mini-
mally involving the ovaries with microscopic or small
macroscopic cancer deposits on the surface of the ovary
[1].
It has been shown with the use of histopathologic criteria
that these tumors appear more like Mullerian neoplasms
than classic mesotheliomas [2].
Since PPC has the appearance of a 'Mullerian' carcinoma
and simulates ovarian cancer clinically, distant metastases
may occur in the pleura, lung, liver and lymph nodes,
while the central nervous system (CNS) remains one of
the uncommon sites of metastases [3,4]. Moreover, eye
involvement from such malignancies is exceedingly rare,
with only seven cases of epithelial ovarian cancer being
reported in the literature [5-9].
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There is no documented case in the literature of choroid
metastasis in a patient with primary peritoneal carcinoma
(PPC). This case represents the first documented report of
choroidal eye metastasis from PPC. We also review briefly
the related literature using a Medline search and discuss
our findings in the present case.
Case presentation
A 54-year-old Caucasian woman presented with abdomi-
nal distension and on clinical examination was found to
have a large ovarian cyst extending up to the xiphister-
num. Abdomino-pelvic ultrasound confirmed a multi-
loculated cyst. Nineteen years previously she had under-
gone total abdominal hysterectomy and left salpingo-
oopherectomy for endometriosis. The CA 125 level was
within the normal limits at 25 u/ml. Laparotomy, wash-
ings, right salpingo-oophorectomy and omentectomy was
performed. Histology showed a borderline mucinous
tumour and the peritoneal washings showed reactive mes-
othelial cells, FIGO stage 1A. After the multidisciplinary
team meeting, no further treatment was recommended.
The CA 125 level reverted to normal and she was dis-
charged from hospital follow-up in August 2004.
Four months later she presented with right-sided upper
abdominal pain. CA125 was found to be raised 2036 u/
ml. Computed tomography (CT) of the abdomen and pel-
vis revealed ascites with disseminated peritoneal deposits
and a solitary left lower lobe lung metastasis, but no evi-
dence of malignant disease in the upper abdomen includ-
ing pancreas. Diagnostic laparoscopy and biopsies were
performed; the findings were those of miliary peritoneal
and diaphragmatic disease and an omental cake adherent
to anterior abdominal wall. The histology of the biopsy
from the diaphragm and peritoneum revealed a poorly
differentiated adenocarcinoma consistent with primary
peritoneal carcinoma. The ascitic fluid was positive for
malignant cells.
The previous pathology including that of the right ovary
from the first laparotomy were reviewed. The patient was
confirmed to have had a borderline mucinous tumour of
the right ovary with the tumour cells staining positive for
cytokeratin 7 (CK7) and CEA but negative for CA 125 and
cytokeratin 20 (CK 20) (Figure 1).
The laparoscopic biopsies taken from the subsequent dis-
seminated peritoneal malignancy showed poorly differen-
tiated adenocarcinoma consistent with primary peritoneal
carcinoma (possible endometrioid type)and showing a
different immunostaining pattern to the previous ovarian
borderline mucinous tumour with positive expression of
cytokeratin 7(CK7) and CA 125 but negative for CEA and
CK 20. (Figure 2).
Subsequently the patient received three cycles of neoadju-
vant chemotherapy with carboplatin and paclitaxel fol-
lowed by interval debulking surgery that revealed two
areas of disease in the omentum, which were excised. The
end result was optimal cytoreduction with no intra-
abdominal macroscopic disease. The final histology con-
firmed poorly differentiated adenocarcinoma. Post-opera-
tively a further three cycles of chemotherapy was given
with the CA 125 level normalised to 22 u/ml by the end
of treatment.
Four months later, the patient again presented with raised
CA 125 at 198 u/ml and pain under her left lower ribs.
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Computed tomography of abdomen and pelvis showed
tumour recurrence in the abdomen with pulmonary and
liver metastases. The patient was then started on second
line chemotherapy with liposomal doxorubicin.
After 8 cycles of liposomal doxorubicin a CT scan of the
abdomen and pelvis showed enlarged liver metastases
with evidence of progressive disease. The CA 125 level had
further increased to 724 u/ml.
One month later, she presented with one-week history of
blurring of vision in the left eye. She was referred for oph-
thalmologic evaluation, where the bilateral anterior seg-
ments, the pupils and lenses including the fundus of the
right eye were found to be normal. However, fundoscopy
of the left eye revealed a creamy dome shaped mass in the
superior part of the left fundus. Further investigations
with diagnostic ultrasonography of the ocular structures
were then performed. The patient underwent A (ampli-
tude modulation) and B (brightness modulation) ultra-
sound scan of the eye (the A-scan usually reveals medium
to high internal reflectivity while the B-scan will show
acoustic solidity) [10]. The A scan showed medium to
high internal reflectivity irregular maximum elevation of
2.29 mm (figure 3), while the B scan showed a dome
shaped lesion in the superior part of left fundus with sur-
rounding elevation of the retina (figure 4). The ophthal-
moscopic and ultrasound investigations were consistent
with choroidal metastasis. The patient subsequently
received palliative radiotherapy of 20 Gy in 5 fractions fol-
lowing which her symptoms of blurred vision and pain in
the left eye improved.
The patient's condition steadily deteriorated from then on
with pain in the right hypochondrium, right shoulder and
right posterior chest associated with breathlessness. Com-
puted tomography pulmonary angiography (CTPA)
revealed left lower lung metastases with mediastinal
encasement by metastatic disease with secondary pericar-
dial effusion and a moderate left pleural effusion and
small pulmonary emboli. The pleural and pericardial effu-
sions were drained to control symptoms. The cytology of
the pericardial fluid confirmed the presence of malignant
cells. She subsequently developed refractory renal failure
and died.
Conclusion
The incidence of metastatic carcinoma to the eye varies by
reports and ranges from 10% – 12.6% in autopsy studies
of patients with disseminated cancer [11,12] to 0.07% –
2.3% in patients with advanced generalized malignancy
[13]. The commonnest primary site is breast cancer in 47–
49% of cases and lung cancer in 14–21% of cases [14,15].
The choroid is the most common site in the eyes, with
uveal metastases (88%) whereas 9% locate in the iris and
2% in the ciliary body. The tumours occur most often in
the posterior pole of the eye with an average of two
focuses per eye [14].
Ovarian cancer metastatic to the central nervous system
(CNS) is reported to occur in less than 1.5% of all ovarian
cancer metastases [4,16]. The incidence of CNS metastases
in patients with ovarian cancer is reported to range from
0.29% in a review of 4456 patients [17] to 1.2% in an
autopsy study of 86 patients [18].
Choroidal involvement from gynaecological malignan-
cies is extremely rare. A review of the literature found only
seven cases of choroidal involvement from ovarian carci-
noma [5-9,19,20] four cases from cervical cancer
[13,21,22] and one case of endometrial adenocarcinoma
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[23]. The choroidal metastases are usually diagnosed on
fundoscopy, while imaging techniques including ultra-
sound examination of the eye, CT scan of the head and
orbit and MRI scanning are used as well. Fluorescein ang-
iography may be helpful showing early hyperfluorescence
and diffuse late staining of the lesion [9,19,20,23,24]. In
our case the patient had disseminated primary peritoneal
carcinoma with evidence of systemic recurrence in the
liver and lungs and therefore the eye metastasis was
deemed to originate from disseminated primary perito-
neal carcinoma.
We believe that the present case is the first reported case of
PPC with metastasis to the choroid of the eye. Moreover,
this patient is unique in that the choroidal metastases
occurred within three years of having a borderline muci-
nous tumour of the ovary and primary peritoneal carci-
noma. In respect to the patient's history of endometriosis
it is possible that the disseminated peritoneal tumour may
have originated from endometriosis of the peritoneal sur-
faces. It has been reported that 69% of the malignancy
arising from extra-gonadal sites of endometriosis includ-
ing the pelvic peritoneum show endometrioid differentia-
tion [25].
Although the primary mode of dissemination for EOC
and PPC is by transcoelomic spread, haematogenous
spread can occur. It seems that the high vascularity of the
uvea and specifically of the choroid predisposes the eye to
intraocular metastases. The average survival time of
patients with choroidal metastasis from any primary car-
cinoma is 8–9 months after diagnosis [26]. Review of the
reported cases showed that the mean duration from diag-
nosis of EOC to detection of choroidal metastases was 23
months and the mean duration from diagnosis of metas-
tases to death was 8 months [5-9,19,20]. Our patient's
choroidal eye metastases appeared 21 months after PPC
was diagnosed
Although prognosis is poor, treatment of the eyes should
be considered in order to preserve the visual function and/
or relieve pain. Local radiotherapy has been shown to be
an effective approach and provides significant palliation
of symptoms [10], whereas multimodal treatment
approach including systemic chemotherapy and local
radiotherapy appears to be another option. Transpupil-
lary thermotherapy (TTT) with diode laser can be used for
deposits of medium thickness and minimal amount of
subretinal fluid [24]. Response to treatment has been
reported to be about 81% with remission of ocular disease
in 59% [27]. In cases of painful blind eye, enucleation
may be considered [24].
Since the incidence of distant metastasis from PPC
appears to be increasing [6], we believe that both the ear-
lier recognition of the disease and the use of effective
chemotherapeutic regimens might offer patients signifi-
cant local control and long-term survival benefit allowing
occult metastatic disease to be picked up and therefore
treated earlier. Although metastases to the eyes are unu-
sual, this case demonstrates the need for suspicion and
prompt investigation of patients with visual complaints
and history of primary peritoneal carcinoma.
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